PlainRecalls
FDA Drug Critical Class I Ongoing

ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com

Reported: December 11, 2024 Initiated: November 4, 2024 #D-0085-2025

Product Description

ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Details

Recalling Firm
Boulla LLC
Units Affected
Unknown
Distribution
Nationwide within the United States
Location
Sacramento, CA

Frequently Asked Questions

What product was recalled?
ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com. Recalled by Boulla LLC. Units affected: Unknown.
Why was this product recalled?
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 11, 2024. Severity: Critical. Recall number: D-0085-2025.